Aclaris Therapeutics, Inc. (ACRS) Stock Analysis

Free AI-powered analysis and research for Aclaris Therapeutics, Inc. stock

Sector: Healthcare

Analyze Aclaris Therapeutics, Inc. (ACRS) Stock

Aclaris Therapeutics, Inc. (ACRS) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into ACRS stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Aclaris Therapeutics, Inc. stock.

📰 Latest Update

Wall Street Analysts Believe Aclaris (ACRS) Could Rally 69.2%: Here's is How to Trade

Mon, August 10, 2026 at 1:55 PM UTC 2 min read

Wall Street analysts are optimistic about Aclaris Therapeutics (ACRS), projecting a potential rally of 69.2% in the stock price. This bullish outlook is driven by the company's promising pipeline and recent developments that could enhance its market position. Investors may want to consider this potential upside when evaluating their portfolios, as such forecasts suggest significant growth opportunities for ACRS in the near future.

Read full article →

Why Analyze Aclaris Therapeutics, Inc. (ACRS) with StockIQ?

• ✅ Free AI-powered analysis of Aclaris Therapeutics, Inc. (ACRS) stock
• ✅ Real-time technical indicators for Aclaris Therapeutics, Inc. stock
• ✅ Comprehensive risk assessment for ACRS
• ✅ No credit card required

People also watch